The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hillsberg Sanford since 2006.
The trader's CIK number is 1297696.
At the time of the last reporting, Hillsberg Sanford was the 10% Owner of Iovance Biotherapeutics, Inc.. (stock ticker symbol IOVA).
Also see all insider trading activities at Iovance Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | GALE | 0 | $0 | 450,000 | $2,737,500 | 450,000 | $531,250 |
| 2013 | GALE | 0 | $0 | 0 | $0 | 50,000 | $36,000 |
| 2010 | GALE | 0 | $0 | 25,000 | $141,500 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | LBIO | 0 | $0 | 54,000 | $491,724 | 0 | $0 |
| 2015 | LBIO | 0 | $0 | 115,000 | $991,960 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | DSKT | 0 | $0 | 12,500 | $562 | 0 | $0 |
| 2006 | DSKT | 0 | $0 | 288,100 | $69,873 | 0 | $0 |
1. Sellas Life Sciences Group, Inc. (GALE)
2. Iovance Biotherapeutics, Inc. (LBIO)
3. Duska Therapeutics, Inc. (DSKT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-30 | GALE | Option Ex | 250,000 | 1.45 | 361,250 |
| 2014-01-30 | GALE | Sale | 250,000 | 5.41 | 1,352,500 |
| 2014-01-17 | GALE | Sale | 200,000 | 6.92 | 1,385,000 |
| 2014-01-14 | GALE | Option Ex | 200,000 | .85 | 170,000 |
| 2013-12-12 | GALE | Option Ex | 50,000 | .72 | 36,000 |
| 2010-03-26 | RXII | Sale | 25,000 | 5.66 | 141,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-08-22 | LBIO | Sale | 54,000 | 9.11 | 491,724 |
| 2015-09-04 | LBIO | Sale | 16,000 | 6.84 | 109,440 |
| 2015-09-08 | LBIO | Sale | 16,500 | 7.13 | 117,645 |
| 2015-08-03 | LBIO | Sale | 32,500 | 8.15 | 264,875 |
| 2015-05-06 | LBIO | Sale | 50,000 | 10.00 | 500,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-01-04 | DSKT | Sale | 12,500 | .04 | 562 |
| 2006-10-23 | DSKT | Sale | 50,000 | .09 | 4,500 |
| 2006-09-06 | DSKT | Sale | 16,400 | .10 | 1,722 |
| 2006-08-02 | DSKT | Sale | 7,000 | .11 | 770 |
| 2006-08-03 | DSKT | Sale | 7,200 | .11 | 792 |
| 2006-07-25 | DSKT | Sale | 10,000 | .09 | 900 |
| 2006-07-14 | DSKT | Sale | 10,000 | .16 | 1,600 |
| 2006-07-10 | DSKT | Sale | 20,000 | .15 | 3,100 |
| 2006-07-11 | DSKT | Sale | 30,000 | .16 | 4,800 |
| 2006-06-29 | DSKT | Sale | 25,000 | .21 | 5,250 |
| 2006-06-27 | DSKT | Sale | 10,000 | .26 | 2,600 |
| 2006-06-09 | DSKT | Sale | 30,000 | .41 | 12,150 |
| 2006-06-08 | DSKT | Sale | 20,000 | .41 | 8,139 |
| 2006-06-05 | DSKT | Sale | 15,000 | .45 | 6,750 |
| 2006-06-06 | DSKT | Sale | 10,000 | .41 | 4,100 |
| 2006-06-02 | DSKT | Sale | 10,000 | .47 | 4,650 |
| 2006-06-01 | DSKT | Sale | 14,000 | .45 | 6,300 |
| 2006-05-30 | DSKT | Sale | 3,500 | .50 | 1,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hillsberg Sanford (10% Owner of Iovance Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.